Kcentra 500UNIT 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FHYR3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,428
Award facts
- Contract value 100% obligated
- $12,427.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $12,427.52 to DMS Pharmaceutical Group Inc. for 500 units of Kcentra on November 25, 2025, with completion expected by December 12, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation. This delivery order represents one of numerous purchases issued to the vendor under its broader federal pharmaceutical supply relationship with the Department of Defense.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to supply pharmaceutical products to military healthcare facilities worldwide. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. As one of multiple regional prime vendor contractors, DMS Pharmaceutical Group has demonstrated consistent performance fulfilling specialized pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHYR3?
SPE2DR26FHYR3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FHYR3 worth?
The government has obligated $12,428 on SPE2DR26FHYR3.
Is contract SPE2DR26FHYR3 an order under another contract?
Yes. SPE2DR26FHYR3 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHYR3 competed?
The extent of competition for SPE2DR26FHYR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award